Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
What is Glioblastoma Multiforme?Glioblastoma multiforme (GBM) (also called glioblastoma) is a fast-growing type of gliomas, which are the most common form of primary tumors of the central nerv...
The present Glioblastoma multiforme (GBM) market has several unmet needs. Poor prognosis, 10-15 months median survival rate, no curative treatment to the patients, limited treatment options, drug ...
Headaches. Blurred vision. Nausea. No or poor appetite. Behavioral changes. Trouble thinking. These are some common problems people experience in their daily lives; however, are easy to write off ...
Bexion Pharmaceuticals’ Early-Stage Cancer Drug, BXQ-350 Hailed as Game Changer For the Treatment of solid tumors and gliomasBexion Pharmaceuticals’ investigational cancer treatment, BXQ-350, i...
Idera Pharmaceuticals Present Positive Phase I Data for their Drug candidate IMO-2125 Idera Pharmaceuticals announced final results from the dose-selection phase of an ongoing Phase 1/2 trial inves...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...
West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
.png)
